{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-24-000910","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.601202+00:00","generated_at":"2026-06-01T03:52:30.376736+00:00","sec_items":["3.01","5.07","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nutex Health receives Nasdaq exception until July 22 to effect reverse stock split and regain $1 bid price","bullets":["Nasdaq Hearings Panel granted Nutex exception until July 22, 2024 to execute reverse split and regain $1.00 minimum bid.","Stockholders approved reverse stock split (1-for-2 to 1-for-16); board to set exact ratio within one year.","Company had already done a 1-for-15 reverse split in April 2024 but still not compliant; delisting if not cured by July 22.","Annual meeting also elected all director nominees, approved executive compensation, and ratified Marcum LLP as auditor for FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-000910","json":"https://secwatch.observer/filing/0001079973-24-000910.json","markdown":"https://secwatch.observer/filing/0001079973-24-000910.md","text":"https://secwatch.observer/filing/0001079973-24-000910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000107997324000910/0001079973-24-000910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000107997324000910/nutx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:52:30.376736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}